Abits
ABTS
Bit Origin
BTOG
TeraWulf
WULF
BIGG DIGITAL ASSETS INC
BBKCF
NEPTUNE DIGITAL ASSETS CORP
NPPTF
US Stock MarketDetailed Quotes
OLMA Olema Pharmaceuticals
- 5.830
- +0.220+3.92%
Close Dec 31 16:00 ET
- 5.830
- 0.0000.00%
Post 16:00 ET
430.29MMarket Cap-2.56P/E (TTM)
5.980High5.580Low2.08MVolume5.610Open5.610Pre Close12.01MTurnover5.08%Turnover RatioLossP/E (Static)73.81MShares16.77552wk High2.16P/B239.08MFloat Cap5.55652wk Low--Dividend TTM41.01MShs Float60.270Historical High--Div YieldTTM7.13%Amplitude2.000Historical Low5.763Avg Price1Lot Size
About Olema Pharmaceuticals Company
Olema Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of next generation targeted therapies for women’s cancers. Its product candidate, OP-1250, is a novel oral therapy with combined activity as both a complete ER antagonist, or CERAN, and a selective ER degrader, or SERD, which is believed to drive deeper, more durable responses than existing therapies. The company was founded by Cyrus L. Harmon and Peter J. Kushner on August 7, 2006 and is headquartered in San Francisco, CA.
Company Profile
SymbolOLMA
Company NameOlema Pharmaceuticals
Listing DateNov 19, 2020
Issue Price19.00
Founded2006
CEODr. Sean P. Bohen, M.D.
MarketNASDAQ
Employees74
Fiscal Year Ends12-31
Address780 Brannan Street
CitySan Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94103
Phone1-650-243-5555
Websitehttp://www.olema.com
Company Executives
- Name
- Position
- Salary
- Dr. Sean P. Bohen, M.D.
- Director, President and Chief Executive Officer
- 3.15M
- Shane Kovacs
- Principal Accounting Officer, Chief Operating and Financial Officer
- 1.55M
- Dr. David C. Myles, PhD
- Chief Discovery and Non-Clinical Development Officer
- --
- Dr. Naseem Zojwalla, M.D.
- Chief Medical Officer
- 1.30M
- Ian T. Clark
- Chairman of the Board
- 198.65K
- Dr. Cyrus L. Harmon, PhD
- Director
- 1.33M
- Scott Garland
- Independent Director
- 280.21K
- Andrew S. Rappaport
- Independent Director
- 176.65K
- Yi Larson
- Independent Director
- 163.15K
- Dr. Graham Waley, M.D.,PhD
- Independent Director
- 171.15K
- Cynthia M. Butitta
- Independent Director
- 180.15K
- Dr. Sandra J. Horning, M.D.
- Independent Director
- 158.15K
- Dr. Gorjan Hrustanovic, PhD
- Independent Director
- 165.15K
Trending US Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.